Hyogo, Japan

Fumio Shiomojo


Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 48(Granted Patents)


Location History:

  • Kawanishi, JP (2002)
  • Hyogo, JP (2003)

Company Filing History:


Years Active: 2002-2003

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Fumio Shiomojo: Innovator in Medicinal Aerosol Compositions

Introduction

Fumio Shiomojo is a notable inventor based in Hyogo, Japan. He has made significant contributions to the field of medicinal aerosol compositions, holding a total of 2 patents. His work focuses on improving the uniformity and effectiveness of aerosol delivery systems.

Latest Patents

One of Fumio Shiomojo's latest patents involves the use of a medium-chain fatty acid triglyceride as a dispersant in the preparation of a medicinal aerosol composition. This innovative approach describes how a tricyclic compound is dispersed in a liquefied hydrofluoroalkane propellant. By adding a liquefied hydrofluoroalkane to a kneaded premix of the tricyclic compound and the medium-chain fatty acid triglyceride, the active ingredient achieves an even distribution. This method enhances the uniformity of the active ingredient's content in the aerosol composition, making it more effective for medicinal use.

Career Highlights

Fumio Shiomojo is currently employed at Fujisawa Pharmaceutical Company, Ltd., where he continues to develop innovative solutions in the pharmaceutical industry. His expertise in aerosol compositions has positioned him as a key figure in advancing medicinal delivery systems.

Collaborations

Throughout his career, Fumio has collaborated with esteemed colleagues such as Saburo Murata and Yuji Tokunaga. These partnerships have contributed to the development of groundbreaking technologies in the field of medicinal aerosols.

Conclusion

Fumio Shiomojo's work in aerosol compositions exemplifies the importance of innovation in the pharmaceutical industry. His contributions are paving the way for more effective medicinal delivery systems, ultimately benefiting patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…